1. Home
  2. MUA vs MLAB Comparison

MUA vs MLAB Comparison

Compare MUA & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackrock MuniAssets Fund Inc

MUA

Blackrock MuniAssets Fund Inc

N/A

Current Price

$9.86

Market Cap

666.0M

Sector

Finance

ML Signal

N/A

Logo Mesa Laboratories Inc.

MLAB

Mesa Laboratories Inc.

N/A

Current Price

$127.45

Market Cap

719.9M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
MUA
MLAB
Founded
N/A
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Industrial Machinery/Components
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
666.0M
719.9M
IPO Year
1994
1995

Fundamental Metrics

Financial Performance
Metric
MUA
MLAB
Price
$9.86
$127.45
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 299.3K
72.2K
Earning Date
01-01-0001
11-09-2026
Dividend Yield
N/A
★ 0.54%
EPS Growth
N/A
★ 436.11
EPS
N/A
★ 0.49
Revenue
N/A
N/A
Revenue This Year
N/A
$2.14
Revenue Next Year
N/A
$6.45
P/E Ratio
★ N/A
$257.53
Revenue Growth
N/A
N/A
52 Week Low
$9.13
$69.51
52 Week High
$11.26
$144.35

Technical Indicators

Market Signals
Indicator
MUA
MLAB
Relative Strength Index (RSI) 60.52 47.10
Support Level $9.62 $120.65
Resistance Level $10.04 $135.25
Average True Range (ATR) 0.17 5.23
MACD 0.03 -0.75
Stochastic Oscillator 73.04 40.09

Price Performance

Historical Comparison
MUA
MLAB

About MUA Blackrock MuniAssets Fund Inc

Blackrock Muniassets Fund Inc is a closed-end fund. Its objective is to provide high current income exempt from U.S. federal income taxes by investing in a portfolio of medium- to lower-grade or unrated municipal obligations. The Fund invests more of its total assets in municipal bonds.

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.

Share on Social Networks: